Systemic lupus erythematosus (SLE) is rare in India with a prevalence of 3 in 100,000.\[[@ref1]\] SLE retinopathy is second most common ocular manifestation after keratoconjunctivitis sicca and a major vision-threatening complication of SLE with an incidence of upto 29% in patients with systemic active disease.\[[@ref2]\]

We present this photo essay to illustrate the classic features of SLE retinopathy and the co-ordinated role of Ophthalmologist (including sub-specialties) with Physicians (Rheumatologist and/or Dermatologist) in managing these multi-system and multi-organ autoimmune disorders.

Case Report {#sec1-1}
===========

A 32-year-old female patient presented with diminution of vision in both eyes since 3 months. She had a history of miscarriage in the first trimester, 1 year back. Physical examination revealed malar rash and discoid skin rash on the trunk and extremities \[[Fig. 1](#F1){ref-type="fig"}\]. Best corrected visual acuity was 20/200 in right and 20/40 in the left eye. Biomicroscopic examination of anterior segment, intraocular pressure and Schirmer\'s test were within the normal limits in both eyes. Fundus examination revealed cotton-wool spots, multiple large-vessel branch retinal artery occlusion (BRAO) with macular ischemia in right eye and superotemporal BRAO sparing macula in left eye \[Figs. [2](#F2){ref-type="fig"}--[6](#F6){ref-type="fig"}\]. She was referred to Rheumatologist and Dermatologist who diagnosed her with SLE. Laboratory investigations were positive for antinuclear antibodies and antidouble stranded/native DNA antibodies. Rest of her systemic investigations including anti-phospholipid antibodies were negative. Treatment was initiated with oral azathioprine, hydroxychloroquine, and steroids.

![External photograph demonstrating malar rash on face, discoid skin rash over extensor surface of upper limbs with sparing of nails](IJO-62-951-g001){#F1}

![Right eye fundus montage photo showing pale optic disc, multiple large vessel branch retinal artery occlusions, vessel sheathing and cotton wool spots](IJO-62-951-g002){#F2}

![Right eye fundus fluoroscein angiography montage photo showing multiple large arteriole occlusions with macular ischemia](IJO-62-951-g003){#F3}

![Left eye fundus montage photograph showing multiple cotton wool spots scattered over posterior pole](IJO-62-951-g004){#F4}

![Left eye fundus angiography montage photograph showing supero-temporal arterioles occlusion (arrow heads) with macular sparing](IJO-62-951-g005){#F5}

![Spectral domain-optical coherence tomography image with raster line scan running through fovea demonstrates foveal thinning in right eye attributable to macular branch retinal artery occlusion (foveal thickness = 114 μ). Left eye scan demonstrates shadowing (nasal side) secondary to extensive cotton wool spots (foveal thickness = 164 μ)](IJO-62-951-g006){#F6}

Discussion {#sec1-2}
==========

Retinopathy is an important manifestation of SLE, which develops with an incidence of 3-29%.\[[@ref3]\] SLE retinopathy points to active lupus, anti-phospholipid antibody syndrome (APS), central nervous system lupus or drug-induced. Fundus examination is important because ocular fundus is the only part of the human body where small vessels can be directly visualized in a noninvasive manner. Life-table survival estimates have shown decreased survival in patients with SLE retinopathy, compared to SLE patients without retinopathy.\[[@ref3]\]

A characteristic finding of lupus retinopathy is vasculitis of retinal capillaries associated with local microinfarction.\[[@ref4]\] Large retinal vessel occlusions (central or branch; vein or arteriole) are more common with APS associated with SLE.\[[@ref5]\] The mainstay of treatment is systemic immune-suppression.

Even though, ocular manifestations do not constitute the diagnostic criteria for SLE, they accurately indicate active systemic lupus; occult or overt. Early diagnosis, prompt referral, systemic immune-suppression and co-ordinated treatment strategies involving sub- multidisciplinary ophthalmologists, rheumatologist, and dermatologist play a key role in reducing ocular and systemic morbidity associated with SLE.
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